Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $305.9200 (3.21%) ($298.5200 - $306.3700) on Fri. Jul. 18, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 74 | Latest Price | $305.9200(3.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.1% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
5 Day Moving Average | $307.71(-0.58%) | 10 Day Moving Average | $310.02(-1.32%) | 20 Day Moving Average | $300.16(1.92%) | To recent high | -3.8% | To recent low | 10.3% | Market Cap | $32.436b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |